Cargando…

Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient

Introduction: Adrenal Carcinoma (AC) is a rare endocrine malignancy of the adrenal glands. It can affect up to 3–10% of the human population. It is common in children as secondary malignancies or as a manifestation of a tumor syndrome. Typically patients with AC start to become symptomatic after ext...

Descripción completa

Detalles Bibliográficos
Autores principales: AlJedaani, Samia Mohammad, Al-Obaydi, Sarah, Shah, Aesha, Fan, Chris, Manni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089360/
http://dx.doi.org/10.1210/jendso/bvab048.313
_version_ 1783687029769371648
author AlJedaani, Samia Mohammad
Al-Obaydi, Sarah
Shah, Aesha
Fan, Chris
Manni, Andrea
author_facet AlJedaani, Samia Mohammad
Al-Obaydi, Sarah
Shah, Aesha
Fan, Chris
Manni, Andrea
author_sort AlJedaani, Samia Mohammad
collection PubMed
description Introduction: Adrenal Carcinoma (AC) is a rare endocrine malignancy of the adrenal glands. It can affect up to 3–10% of the human population. It is common in children as secondary malignancies or as a manifestation of a tumor syndrome. Typically patients with AC start to become symptomatic after extensive tumor development- 10–13 cm. The presentation of AC includes signs of hormone excess. The most common hormone in excess is cortisol. Thus individuals with AC typically present with symptoms of hypercortisolism or Cushing’s Syndrome. In chronic cases the high concentration of glucocorticoids can start stimulating aldosterone receptors causing hypertension and hypokalemia. Furthermore, patients with AC also have symptoms of tumor growth, such as abdominal pain, flank pain, and early satiety. Currently prognostic factors for AC are undefined. AC generally has a poor prognosis as a majority of patients are diagnosed during advanced stage of disease (stage IV). Furthermore, it was found that patients with stage IV disease had a survival of less than one year. Currently the only curative treatment is complete tumor resection. Medical management with chemotherapy can be utilized in cases of extensive metastasis and poor prognosis. A common chemotherapeutic agent is mitotane, which is a steroidogenesis inhibitor. Case Presentation:Patient is a 19 year old female, who initially presented to her primary care provider’s (PCP) office for an annual wellness visit during August 2020. She was subsequently discovered to have elevated blood pressure. At this time she was not symptomatic. She was advised on lifestyle modifications. She was also stopped on her birth control medication. Furthermore, she later presented to her PCP with continued elevated blood pressure, still not symptomatic. In an outpatient cardiology office, she presented with blood pressures in the 200s/100s range and a new murmur. She was sent to the ED for evaluation (11/2020). On her presentation to the ED, she still did not have any symptoms. She also denied any fatigue or unintentional weight changes. Her only concern was mild edema in the lower legs after standing for extended periods of time. Her medical history was insignificant. Her family history was significant for her paternal essential HTN diagnosed in the early 20s. Laboratory evaluation revealed unremarkable electrolyte levels and CBC. Furthermore, her TSH level was also normal. A chest ray revealed multiple pulmonary nodules ranging from 3–5 mm. A renal ultrasound revealed a large mass in the RUQ (16.9x9.6x12 cm). She was also found to have mildly elevated cortisol levels at 22.9, suppressed ACTH levels, and normal levels of aldosterone and metanephrines. Subsequent CT imaging and biopsy revealed adrenal carcinoma with extensive metastasis to the lungs and liver. Patient was referred to Oncology service to start Chemotherapy.
format Online
Article
Text
id pubmed-8089360
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80893602021-05-06 Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient AlJedaani, Samia Mohammad Al-Obaydi, Sarah Shah, Aesha Fan, Chris Manni, Andrea J Endocr Soc Adrenal Introduction: Adrenal Carcinoma (AC) is a rare endocrine malignancy of the adrenal glands. It can affect up to 3–10% of the human population. It is common in children as secondary malignancies or as a manifestation of a tumor syndrome. Typically patients with AC start to become symptomatic after extensive tumor development- 10–13 cm. The presentation of AC includes signs of hormone excess. The most common hormone in excess is cortisol. Thus individuals with AC typically present with symptoms of hypercortisolism or Cushing’s Syndrome. In chronic cases the high concentration of glucocorticoids can start stimulating aldosterone receptors causing hypertension and hypokalemia. Furthermore, patients with AC also have symptoms of tumor growth, such as abdominal pain, flank pain, and early satiety. Currently prognostic factors for AC are undefined. AC generally has a poor prognosis as a majority of patients are diagnosed during advanced stage of disease (stage IV). Furthermore, it was found that patients with stage IV disease had a survival of less than one year. Currently the only curative treatment is complete tumor resection. Medical management with chemotherapy can be utilized in cases of extensive metastasis and poor prognosis. A common chemotherapeutic agent is mitotane, which is a steroidogenesis inhibitor. Case Presentation:Patient is a 19 year old female, who initially presented to her primary care provider’s (PCP) office for an annual wellness visit during August 2020. She was subsequently discovered to have elevated blood pressure. At this time she was not symptomatic. She was advised on lifestyle modifications. She was also stopped on her birth control medication. Furthermore, she later presented to her PCP with continued elevated blood pressure, still not symptomatic. In an outpatient cardiology office, she presented with blood pressures in the 200s/100s range and a new murmur. She was sent to the ED for evaluation (11/2020). On her presentation to the ED, she still did not have any symptoms. She also denied any fatigue or unintentional weight changes. Her only concern was mild edema in the lower legs after standing for extended periods of time. Her medical history was insignificant. Her family history was significant for her paternal essential HTN diagnosed in the early 20s. Laboratory evaluation revealed unremarkable electrolyte levels and CBC. Furthermore, her TSH level was also normal. A chest ray revealed multiple pulmonary nodules ranging from 3–5 mm. A renal ultrasound revealed a large mass in the RUQ (16.9x9.6x12 cm). She was also found to have mildly elevated cortisol levels at 22.9, suppressed ACTH levels, and normal levels of aldosterone and metanephrines. Subsequent CT imaging and biopsy revealed adrenal carcinoma with extensive metastasis to the lungs and liver. Patient was referred to Oncology service to start Chemotherapy. Oxford University Press 2021-05-03 /pmc/articles/PMC8089360/ http://dx.doi.org/10.1210/jendso/bvab048.313 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adrenal
AlJedaani, Samia Mohammad
Al-Obaydi, Sarah
Shah, Aesha
Fan, Chris
Manni, Andrea
Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient
title Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient
title_full Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient
title_fullStr Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient
title_full_unstemmed Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient
title_short Rare Case of Huge Adrenocortical Carcinoma in Surprisingly Asymptomatic Patient
title_sort rare case of huge adrenocortical carcinoma in surprisingly asymptomatic patient
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089360/
http://dx.doi.org/10.1210/jendso/bvab048.313
work_keys_str_mv AT aljedaanisamiamohammad rarecaseofhugeadrenocorticalcarcinomainsurprisinglyasymptomaticpatient
AT alobaydisarah rarecaseofhugeadrenocorticalcarcinomainsurprisinglyasymptomaticpatient
AT shahaesha rarecaseofhugeadrenocorticalcarcinomainsurprisinglyasymptomaticpatient
AT fanchris rarecaseofhugeadrenocorticalcarcinomainsurprisinglyasymptomaticpatient
AT manniandrea rarecaseofhugeadrenocorticalcarcinomainsurprisinglyasymptomaticpatient